The ongoing antidepressant and anti-anxiety benefits of brexanolone, a drug approved for the treatment of postpartum depression, for weeks after treatment may lie in how it alters oscillations in regions of the brain associated with mood
Unique research collaborative draws on public health and emergency medical services data and spatial epidemiological analyses to map opioid-related incidents, improve public health response in Lowell, Mass.